Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
Clinical trial NCT06341842 · UNKNOWN
Trial details
- NCT number
- NCT06341842
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2025-04-19
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.